These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 37282614

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vogt-Koyanagi-Harada Relapse after COVID-19 Vaccination.
    Accorinti M, Saturno MC, Manni P.
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1228-1233. PubMed ID: 35201950
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging.
    Fukutsu K, Namba K, Iwata D, Mizuuchi K, Kase S, Suzuki K, Shimizu H, Shibata Y, Yamawaki F, Onozawa M, Ishida S.
    BMC Ophthalmol; 2020 Mar 10; 20(1):94. PubMed ID: 32156266
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids.
    Nakayama M, Keino H, Watanabe T, Okada AA.
    Br J Ophthalmol; 2019 Feb 10; 103(2):274-278. PubMed ID: 29666121
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for subretinal fibrosis in patients with Vogt Koyanagi Harada syndrome.
    Golzarri MF, Cheja-Kalb R, Concha-Del-Río LE, Gonzalez-Salinas R, Arellanes-García L.
    Ocul Immunol Inflamm; 2022 Feb 17; 30(2):265-269. PubMed ID: 33021860
    [Abstract] [Full Text] [Related]

  • 18. Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine.
    Koong LR, Chee WK, Toh ZH, Ng XL, Agrawal R, Ho SL.
    Ocul Immunol Inflamm; 2021 Aug 18; 29(6):1212-1215. PubMed ID: 34505819
    [Abstract] [Full Text] [Related]

  • 19. Clinical and therapeutic features of pediatric Vogt-Koyanagi-Harada disease.
    Albaroudi N, Tijani M, Boutimzine N, Cherkaoui O.
    J Fr Ophtalmol; 2020 May 18; 43(5):427-432. PubMed ID: 32115269
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.